Vanderbilt Institute for Clinical and Translational Research (VICTR)

Wesley Self, MD, MPH
April 11, 2023

VUMC-led trial shows two investigational drugs are ineffective for treating severe COVID-19

A Vanderbilt-led study evaluating two investigational drugs to treat severe COVID-19 demonstrated that neither drug was effective.

By Nancy Humphrey
Recipients of the 2023 Research Staff Awards are, front row from left, Laura Stevens, MS, Kate Von Wahlde, MJ, CCRP, and JoAnn Gottlieb, RDMS, RDCS. Presenting the awards were, back row from left, Jennifer Pietenpol, PhD, Gordon Bernard, MD, and John Kuriyan, PhD.
April 6, 2023

Research Staff Awards honor contributions to discovery

By Bill Snyder
Matthew Semler, MD, MSc, and Cheryl Gatto, PhD, will lead the new Center for Learning Healthcare.
January 26, 2023

VUMC establishes novel Center for Learning Healthcare

Vanderbilt University Medical Center has established a first-of-its-kind Center for Learning Healthcare that will bring together clinicians, health system operations leaders and researchers to generate evidence in the course of health care delivery to continuously improve the quality, value and safety of health care offered to patients.

By Nancy Humphrey
Gordon Bernard, MD, is stepping down from his institutional leadership roles next summer to focus on his research interests.
December 16, 2022

VUMC Announces VICTR Leadership Transition

By Bill Snyder
The clinical trial group includes, from left, Gordon Bernard, MD, Katherine Cahill, MD, Kevin Niswender, MD, PhD, Pingsheng Wu, PhD, and R. Stokes Peebles, MD.
November 10, 2022

Clinical trial at VUMC tests novel treatment for asthma

VUMC has begun enrolling patients with asthma in a clinical trial of a novel treatment: a medication approved to treat diabetes and obesity.

By Leigh MacMillan
(iStock)
October 6, 2022

VUMC to test whether Alzheimer’s drug can ease lupus symptoms

Vanderbilt University Medical Center is partnering with Evergreen Therapeutics Inc. to test whether an Alzheimer’s drug, memantine, can improve cognitive symptoms associated with systemic lupus.

By Bill Snyder
September 29, 2022

Conference highlights REDCap’s global reach

REDCap administrators from around the world recently attended the 14th edition of REDCapCon in Boston, hosted this year by Harvard Catalyst, Harvard University’s center for clinical and translational science.
By Paul Govern
September 22, 2022

Self named co-principal investigator of Vanderbilt’s Clinical and Translational Science Award

Wesley Self, MD, MPH, a physician-scientist at Vanderbilt University Medical Center, has been named co-principal investigator (co-PI) of Vanderbilt’s Clinical and Translational Science Award (CTSA).  
By Bill Snyder
August 25, 2022

New high-tech biobank safeguards critical specimens

By Bill Snyder
August 17, 2022

Researchers discover how salt increases blood pressure

A Vanderbilt research team has discovered that activation of a certain protein complex involved in the inflammatory response in immune cells contributes to salt-sensitive hypertension.
By Leigh MacMillan
July 6, 2022

VUMC and Roivant Social Ventures announce collaboration to develop therapies for underserved populations

Vanderbilt University Medical Center and Roivant Social Ventures (RSV) this week announced an intention to collaborate in developing therapies for traditionally underserved populations and diseases.
By Bill Snyder
June 16, 2022

Researchers add sign language videos to electronic surveys

A new external module in Vanderbilt's REDCap improves electronic survey accessibility for respondents who are deaf. The module makes it easy to embed individual sign language videos for each survey question and answer.
By Paul Govern
April 6, 2022

Major grant renewal to provide five more years of support for VICTR

Vanderbilt University Medical Center has competed successfully for a third renewal of its Clinical and Translational Science Award by the National Institutes of Health.
By Bill Snyder
1 2 3 4 … 8